Vascular Biogenics (NASDAQ:VBLT) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research report released on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance Shares of Vascular Biogenics stock remained flat at $0.25 on Wednesday. The company’s stock had a trading volume of 318,244 shares, […]

Related Keywords

Israel ,United States , ,Vascular Biogenics Company Profile ,Vascular Biogenics Ltd ,Envestnet Asset Management Inc ,Renaissance Technologies ,Advisor Group Holdings Inc ,Medicard Ltd ,Vascular Biogenics ,Free Report ,Get Free Report ,Sigma Investments ,Asset Management ,Advisor Group Holdings ,Group Holdings ,Biogenics Ltd ,Vascular Biogenics Daily ,